Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab. (Q42921533)
Jump to navigation
Jump to search
scientific article published on 30 August 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab. |
scientific article published on 30 August 2010 |
Statements
Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab (English)
Jorge A Garcia
Thomas E Hutson
Paul Elson
C Lance Cowey
Cheryl Nemec
Robert Dreicer
Ronald M Bukowski
Brian I Rini
30 August 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference